GlassScriptPhysician profile
Jason A Sifrit
NPI 1104898014
$6,966.52
in general payments reported to CMS, 2019-2025
20 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $409 · 2021: $433 · 2022: $1,704 · 2023: $1,535 · 2024: $1,008 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,580 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,579.61 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,193.35 | 2019-2025 | Dailies, Tryptyr, Clareon |
| Johnson & Johnson Vision Care, INC. | $1,034.83 | 2019-2025 | Acuvue |
| Mallinckrodt Hospital Products INC. | $1,029.35 | 2020-2025 | Acthar |
| Biotissue Holdings INC. | $781.67 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $472.42 | 2022-2025 | Miebo, Xiidra, Infuse |
| Johnson & Johnson Surgical Vision, INC. | $328.40 | 2019-2024 | Lipiflow System Activator (Disposable) |
| Coopervision INC. | $325.78 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $267.58 | 2019-2024 | |
| Oyster Point Pharma, INC. | $262.03 | 2022-2025 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $235.01 | 2022-2025 | Durysta, Lumigan |
| Dompe US, INC. | $205.50 | 2020-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $202.22 | 2024-2025 | Xdemvy |
| Mallinckrodt Enterprises LLC | $182.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $167.68 | 2022-2023 | |
| Allergan, INC. | $103.08 | 2020-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heru, INC. | $60.53 | 2022 | |
| Shire North American Group INC | $51.25 | 2019 | |
| Quidel Corporation | $25.64 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Sifrit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.